Discover & learn

Licensing Opportunities

Licensing Opportunities

The Babraham Institute aims to maximise the impact of its scientific discoveries; where appropriate this is achieved through commercialisation of its intellectual property rights. This primarily involves licensing new discoveries and technologies to pharma and biotech companies, but in some cases commercialisation is achieved through spinning-out new companies such as Enhanc3D Genomics.

Current licensing opportunities

Human Amnion-Like Epithelial Cells Derived from Human Pluripotent Stem Cells (hPSC)

Using hPSCs as a source of human amnion-like cells provides a standardised, inexpensive and potentially unlimited source of amnion cells

Multiomics Sequencing for Combinatorial Profiling of Genome-Wide Protein Targets and Transcriptome in Single Cells

This novel technology can simultaneously profile multiple histone modifications and transcriptomes, at single-cell resolution

Ampk-ACC1: Novel Approach To Treat Obesity and Other Metabolic Disorders Associated With Ageing

Increased acetyl-coA flux in the lipid synthesis & fatty acid oxidation pathways could lead to treatments for metabolic/age-related diseases